The NOMAD (Novel Biomaterials to Prevent Dental Peri-implant Infections) project’s overarching aim is to revolutionize dental implant technology by developing the next generation of implants that can effectively prevent peri-implant diseases. By achieving this, the project seeks to significantly enhance the long-term success of dental implants, consequently reducing the socio-economic burden associated with these diseases throughout Europe.
To fulfill these critical clinical needs, NOMAD will employ innovative biomaterials in various components of dental implants, such as the implant fixture, abutment, and restoration. These biomaterial innovations will be applied to both traditional titanium (Ti) and emerging zirconia (ZrO2) implants, with the objective of promoting tissue integration and preventing or controlling biofilm formation. This approach aims to mitigate peri-implant diseases, including peri-implant mucositis and peri-implantitis, ultimately extending the lifespan of dental implants.
In summary, NOMAD’s mission is to advance dental implant technology by preventing peri-implant diseases, promoting tissue integration, and reducing biofilm formation. These objectives are crucial for improving patient outcomes and lessening the healthcare and economic impact of peri-implant diseases in Europe.
For more information about the NOMAD project, you can visit their website at https://nomad-horizoneurope.eu/.
Funding scheme: Horizon Europe Program under grant agreement no. 101091669
Period: 2022-2027
Partners: Health House, CRNS, ECL, USiegen, UCM, UMCG, Anthogyr, Glantreo, Croom Medical, Educell, Atrineo
People involved: Annabel Braem & Merve Kübra Aktan